Your browser doesn't support javascript.
Obesity, walking pace and risk of severe COVID-19 and mortality: analysis of UK Biobank.
Yates, Thomas; Razieh, Cameron; Zaccardi, Francesco; Rowlands, Alex V; Seidu, Samuel; Davies, Melanie J; Khunti, Kamlesh.
  • Yates T; Diabetes Research Centre, University of Leicester, Leicester General Hospital, Leicester, UK. ty20@le.ac.uk.
  • Razieh C; National Institute for Health Research (NIHR) Leicester Biomedical Research Centre (BRC), NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK. ty20@le.ac.uk.
  • Zaccardi F; Diabetes Research Centre, University of Leicester, Leicester General Hospital, Leicester, UK.
  • Rowlands AV; National Institute for Health Research (NIHR) Leicester Biomedical Research Centre (BRC), NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK.
  • Seidu S; Diabetes Research Centre, University of Leicester, Leicester General Hospital, Leicester, UK.
  • Davies MJ; Leicester Real World Evidence Unit, Diabetes Research Centre, University of Leicester, Leicester, UK.
  • Khunti K; Diabetes Research Centre, University of Leicester, Leicester General Hospital, Leicester, UK.
Int J Obes (Lond) ; 45(5): 1155-1159, 2021 05.
Article in English | MEDLINE | ID: covidwho-1104458
ABSTRACT
Obesity is an emerging risk factor for coronavirus disease-2019 (COVID-19). Simple measures of physical fitness, such as self-reported walking pace, may also be important risk markers. This analysis includes 412,596 UK Biobank participants with linked COVID-19 data (median age at linkage = 68 years, obese = 24%, median number of comorbidities = 1). As of August 24th 2020, there were 1001 cases of severe (in-hospital) disease and 336 COVID-19 deaths. Compared to normal weight individuals, the adjusted odds ratio (OR) of severe COVID-19 in overweight and obese individuals was 1.26 (1.07, 1.48) and 1.49 (1.25, 1.79), respectively. For COVID-19 mortality, the ORs were 1.19 (0.88, 161) and 1.82 (1.33, 2.49), respectively. Compared to those with a brisk walking pace, the OR of severe COVID-19 for steady/average and slow walkers was 1.13 (0.98, 1.31) and 1.88 (1.53, 2.31), respectively. For COVID-19 mortality, the ORs were 1.44 (1.10, 1.90) and 1.83 (1.26, 2.65), respectively. Slow walkers had the highest risk regardless of obesity status. For example, compared to normal weight brisk walkers, the OR of severe disease and COVID-19 mortality in normal weight slow walkers was 2.42 (1.53, 3.84) and 3.75 (1.61, 8.70), respectively. Self-reported slow walkers appear to be a high-risk group for severe COVID-19 outcomes independent of obesity.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Walking Speed / COVID-19 / Obesity Type of study: Observational study / Prognostic study Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: English Journal: Int J Obes (Lond) Journal subject: Metabolism Year: 2021 Document Type: Article Affiliation country: S41366-021-00771-z

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Walking Speed / COVID-19 / Obesity Type of study: Observational study / Prognostic study Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: English Journal: Int J Obes (Lond) Journal subject: Metabolism Year: 2021 Document Type: Article Affiliation country: S41366-021-00771-z